Focal segmental glomerulosclerosis historical perspective
|
Focal segmental glomerulosclerosis Microchapters |
|
Differentiating Focal segmental glomerulosclerosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Focal segmental glomerulosclerosis historical perspective On the Web |
|
American Roentgen Ray Society Images of Focal segmental glomerulosclerosis historical perspective |
|
FDA on Focal segmental glomerulosclerosis historical perspective |
|
CDC on Focal segmental glomerulosclerosis historical perspective |
|
Focal segmental glomerulosclerosis historical perspective in the news |
|
Blogs on Focal segmental glomerulosclerosis historical perspective |
|
Directions to Hospitals Treating Focal segmental glomerulosclerosis |
|
Risk calculators and risk factors for Focal segmental glomerulosclerosis historical perspective |
It is believed that Theodor Fahr, a German pathologist, first was first to describe "progressive lipoid nephrosis" in 1925 and to draw an illustration of focal segmental glomerulosclerosis (FSGS). At the time, he referred to it as "lipoid nephrosis with degeneration", showing a clear association to minimal change disease. FSGS was then described in 1957 by Dr. Arnold Rich, a pathologist at Johns Hopkins University.[1] His original article "A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis" was originally published in "Bulletin of the Johns Hopkins Hospital".[1] In his original description, he noted the presence of segmental sclerosis in juxtamedullary glomeruli of autopsies of uremic children with nephrosis.[1]